| Withdrawn | A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Blad NCT07342517 | Relmada Therapeutics, Inc. | Phase 3 |
| Not Yet Recruiting | A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder C NCT07464145 | Relmada Therapeutics, Inc. | Phase 3 |
| Withdrawn | A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NM NCT07313891 | Relmada Therapeutics, Inc. | Phase 3 |
| Not Yet Recruiting | Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy NCT07480356 | Protara Therapeutics | Phase 3 |
| Recruiting | Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma NCT07441499 | Tianjin Medical University Second Hospital | — |
| Not Yet Recruiting | INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP NCT07396038 | Necmettin Erbakan University | — |
| Not Yet Recruiting | The Impact of Age and Sex on Anticipated and Experienced Pain in First-Time Outpatient Flexible Cystoscopy NCT07375641 | Kayseri Education and Research Hospital | — |
| Not Yet Recruiting | Phase II Prospective Cohort Study of Intravesical Recombinant Human Type 5 Adenovirus Injection for Treatment NCT07356791 | RenJi Hospital | Phase 2 |
| Not Yet Recruiting | Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer NCT07272603 | Qilu Hospital of Shandong University | EARLY_Phase 1 |
| Recruiting | Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney C NCT07073703 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Not Yet Recruiting | DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC NCT07207824 | Fudan University | Phase 3 |
| Not Yet Recruiting | The Effect of Video Calls With Family Members During Operating Room Waiting on Stress, Anxiety, and Surgical F NCT07203989 | Bitlis Eren University | N/A |
| Not Yet Recruiting | MICROBIOTA AND BLADDER CANCER NCT07080333 | Centre Hospitalier Universitaire de Nice | N/A |
| Not Yet Recruiting | Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients NCT07119996 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 1 |
| Not Yet Recruiting | A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radi NCT07142200 | RenJi Hospital | Phase 2 |
| Recruiting | Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer NCT07067749 | University of Rome Tor Vergata | Phase 3 |
| Not Yet Recruiting | Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial NCT06982690 | National Taiwan University Hospital | N/A |
| Not Yet Recruiting | A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. NCT07064863 | Queen's University | Phase 1 / Phase 2 |
| Not Yet Recruiting | Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation NCT07053722 | Peking University First Hospital | — |
| Not Yet Recruiting | An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Blad NCT07053735 | Peking University First Hospital | Phase 1 |
| Not Yet Recruiting | Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patie NCT06783153 | Mansoura University | Phase 1 / Phase 2 |
| Not Yet Recruiting | Xpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder NCT06751667 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | N/A |
| Recruiting | Selecting Hypoxic Tumours for Treatment Modification NCT06787053 | University of Manchester | — |
| Completed | Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder NCT07279792 | Ain Shams University | Phase 2 / Phase 3 |
| Completed | Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients NCT06657755 | Lanzhou University Second Hospital | — |
| Recruiting | PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma NCT06696742 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Recruiting | Chemoablation for Low-Grade Bladder Cancer NCT07019220 | Ekaterina Laukhtina | Phase 2 |
| Completed | Bp-MRI Based Multi-planar VI-RADS NCT06607250 | The First Affiliated Hospital with Nanjing Medical University | — |
| Withdrawn | A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies NCT01060319 | Stanford University | — |
| Completed | Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer NCT01108055 | Sandy Srinivas | Phase 2 |